New compounds offer a two-for-one punch to fight estrogen-sensitive breast cancer
 

A set of compounds developed by scientists at Scripps Research in Florida target estrogen-sensitive breast cancer cells in new ways, potentially creating better options for patients with treatment-resistant cancers.

More...